PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rare gene glitch may hold clues for schizophrenia -- NIH-funded study

A North Star amid 'a constellation of multiple rare diseases'

Rare gene glitch may hold clues for schizophrenia -- NIH-funded study
2011-02-28
(Press-News.org) Scientists are eyeing a rare genetic glitch for clues to improved treatments for some people with schizophrenia – even though they found the mutation in only one third of 1 percent of patients.

In the study, funded in part by the National Institutes of Health, schizophrenia patients were 14 times more likely than controls to harbor multiple copies of a gene on Chromosome 7. The mutations were in the gene for VIPR2, the receptor for vasoactive intestinal peptide (VIP) – a chemical messenger known to play a role in brain development. An examination of patients' blood confirmed that they had overactive VIP activity.

Discovery of the same genetic abnormality in even a small group of patients buoys hopes for progress in a field humbled by daunting complexity in recent years. The researchers' previous studies had suggested that the brain disorder that affects about 1 percent of adults might, in many cases, be rooted in different genetic causes in each affected individual, complicating prospects for cures.

"Genetic testing for duplications of the VIP receptor could enable early detection of a subtype of patients with schizophrenia, and the receptor could also potentially become a target for development of new treatments," explained Jonathan Sebat, Ph.D., of the University of California, San Diego, who led the research team. "The growing number of such rare duplications and deletions found in schizophrenia suggests that what we have been calling a single disorder may turn out, in part, to be a constellation of multiple rare diseases."

Sebat, a grantee of the NIH's National Institute of Mental Health – and colleagues at 14 research centers world-wide – report on their findings Feb. 23, 2011, in the journal Nature.

"Although such copy number variations may explain only a small fraction of cases, these rare mutations can yield important clues to the underlying causes of more common forms," noted NIMH Director Thomas R. Insel, M.D. "This new finding with VIPR2 suggests a series of important follow up studies, even in people without the mutation."

Schizophrenia is known to have a strong genetic component -- having a parent or sibling with the disorder increases one's risk tenfold. Yet, genetic studies have so far explained relatively few cases of the illness. As hopes wane that common genetic variations might account for many cases, evidence is mounting that patients harbor disproportionately large numbers of individually rare copy number variations (CNVs) – some shared in families, but many apparently unique to one individual.

The VIPR2 CNV is among the first to implicate a specific gene and neurobiological pathway in schizophrenia. CNVs previously identified, spanning dozens of genes, were too large to yield such clues. In the new genome-wide scan, Sebat and colleagues found the mutation in 29 of 8290 patients (.35 percent) compared to only 2 of 7431 healthy controls. A few other schizophrenia-linked CNVs seen in previous studies were also detected.

VIP and its receptor are known to play a role in regulating the growth of neurons and in learning and memory. They are also expressed in the immune and cardiovascular systems and in the gut – hence its name.

When VIP binds to the VIPR2 receptor on a neuron, it triggers a key relay chemical within the cell, called cyclic AMP. The researchers found that both VIP and cyclic AMP were overactive in blood cells of patients with the VIPR2 mutations.

"It's likely that cyclic AMP signaling is disturbed in a larger fraction of patients, so it's possible that a treatment that targets VIPR2 might have benefits even for people who don't have mutations in the VIPR2 gene," said Sebat. "It looks like the volume is turned-up in the whole VIP signaling pathway."

Since the mutations lead to an overexpression of VIPR2, agents that block the receptor, which already exist, might hold potential for treatment development, he added.

In addition to genetic screening of patients for such personalized medicine, Sebat sees opportunities in the new findings for neuroimaging studies. "We must determine how over-expression of VIPR2 impacts the growth, differentiation and function of neurons – and how that influence behavior. Knowing where the VIPR2 gene is expressed in the human brain can point us to specific regions where VIP activity levels may differ between people who carry this mutation and those who don't."

Despite the challenges posed by the complexities of CNVs, Sebat is upbeat about prospects for ultimately making sense of the emerging evidence about schizophrenia genetics.

"We hypothesize that the many different genetic causes of schizophrenia may have something in common," he said. "There may be larger groups of patients who may not share the same mutation but, may share the same underlying neurobiological defect."



INFORMATION:

In addition to NIH, the research was also supported by the Stanley Medical Research Foundation, Bethesda, Md.; the Beyster Family Foundation, La Jolla, Ca. and NARSAD The Brain and Behavior Research Fund, Great Neck, N.Y.

Information about Schizophrenia http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml

Reference

Duplications of the Neuropeptide Receptor VIPR2 Confer Significant Risk for Schizophrenia. Vacic V, McCarthy S, Malhotra D, Murray F, Chou H-H, Peoples A, Makarov V, Yoon S, Bhandari A, Corominas R, Iakoucheva LM, Krastoshevsky O, Krause V, Larach-Walters V, Welsh DK, Craig D, Kelsoe JR, Gershon ES, Leal SM, Aquila M, Morris DW, Gill M, Corvin A, Insel PA, McClellan J, King M-C, Karayiorgou M,Levy DL, DeLisi LE, Sebat J. Nature. 2011 Feb 23.

The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery and cure. For more information, visit the NIMH website.

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit the NIH website.

[Attachments] See images for this press release:
Rare gene glitch may hold clues for schizophrenia -- NIH-funded study

ELSE PRESS RELEASES FROM THIS DATE:

GPs take more than a month to record ovarian cancer diagnosis in one in 10 cases

2011-02-28
Family doctors can take more than a month to record ovarian cancer, once diagnosed by a specialist, in one in 10 cases, indicates research published in the launch issue of the new online journal BMJ Open. Ovarian cancer was also incorrectly or prematurely classified in 11% of cases, the data show. The authors base their findings on the "free text" data available in patient records, which are submitted to the General Practice Research Database (GPRD). The GPRD contains long term anonymised medical data on more than four million patients on the lists of a representative ...

Most 'locked-in syndrome' patients say they are happy

2011-02-28
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open. The findings are likely to challenge the perception that these patients can no longer enjoy quality of life and are candidates for euthanasia or assisted suicide, say the authors. The research team quizzed 168 members of the French Association for Locked in Syndrome on their medical history and emotional state, ...

Baker Institute policy report looks at cybersecurity

2011-02-28
A new article written by a fellow at Rice University's Baker Institute for Public Policy calls on the intelligence community to jointly create a policy on cybersecurity and determine the degree to which the U.S. should protect intellectual property and national infrastructure of other nations. The author also comments on how aggressive the United States should be in its proactive cyber-spying activities. "Treasure Trove or Trouble: Cyber-Enabled Intelligence and International Politics" was authored by Chris Bronk, a fellow of information technology policy at the Baker ...

Serotonin plays role in many autism cases, studies confirm

Serotonin plays role in many autism cases, studies confirm
2011-02-28
SAN ANTONIO (Feb. 24, 2011) — Mouse models are yielding important clues about the nature of autism spectrum disorders, which impact an estimated one in 110 children in the U.S.[1] In labs at the UT Health Science Center San Antonio, researchers are studying strains of mice that inherently mimic the repetitive and socially impaired behaviors present in these disorders. Georgianna Gould, Ph.D., research assistant professor of physiology in the Graduate School of Biomedical Sciences, is eyeing the role that serotonin plays in autism spectrum disorders. Serotonin is known ...

Antioxidants in pecans may contribute to heart health and disease prevention

2011-02-28
Loma Linda, California – A new research study from Loma Linda University (LLU) demonstrates that naturally occurring antioxidants in pecans may help contribute to heart health and disease prevention; the results were published in the January 2011 issue of The Journal of Nutrition. Pecans contain different forms of the antioxidant vitamin E—known as tocopherols, plus numerous phenolic substances, many of them with antioxidant abilities. The nuts are especially rich in one form of vitamin E called gamma-tocopherols. The findings illustrate that after eating pecans, gamma-tocopherol ...

Researcher lists more than 4,000 components of blood chemistry

2011-02-28
After three years of exhaustive analysis led by a University of Alberta researcher, the list of known compounds in human blood has exploded from just a handful to more than 4,000. "Right now a medical doctor analyzing the blood of an ailing patient looks at something like 10 to 20 chemicals," said U of A biochemist David Wishart. "We've identified 4,229 blood chemicals that doctors can potentially look at to diagnose and treat health problems." Blood chemicals, or metabolites, are routinely analyzed by doctors to diagnose conditions like diabetes and kidney failure. ...

Redesign of US donor-liver network could boost transplants by several hundred per year

Redesign of US donor-liver network could boost transplants by several hundred per year
2011-02-28
PITTSBURGH—A redesign of the nation's donor-liver distribution network developed by University of Pittsburgh researchers could result in several hundred more people each year receiving the transplants they need. The team reports in the journal INFORMS Management Science that donor livers currently are doled out to 11 national regions that evolved with little regard for geography and demographics, an arrangement that prevents many livers from getting to prospective recipients in time. The Pitt researchers instead trimmed the network down to six regions that better account ...

New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases

2011-02-28
COLLEGE PARK, Md. - New findings by a University of Maryland-led team of scientists indicate that a genetically engineered fungus carrying genes for a human anti-malarial antibody or a scorpion anti-malarial toxin could be a highly effective, specific and environmentally friendly tool for combating malaria, at a time when the effectiveness of current pesticides against malaria mosquitoes is declining. In a study published in the February 25 issue of the journal Science, the researchers also say that this general approach could be used for controlling other devastating ...

Multiple childbirth linked to increased risk of rare, aggressive 'triple-negative' breast cancer

2011-02-28
SEATTLE – Full-term pregnancy has long been associated with a reduced risk of breast cancer, but a new study finds that the more times a woman gives birth, the higher her risk of "triple-negative" breast cancer, a relatively uncommon but particularly aggressive subtype of the disease. Conversely, women who never give birth have a 40 percent lower risk of such breast cancer, which has a poorer prognosis than other types of breast cancer and doesn't respond to hormone-blocking therapies such as tamoxifen. These findings, from a study led by Amanda Phipps, Ph.D., a postdoctoral ...

Just like cars, developmental genes have more than 1 way to stop

2011-02-28
EAST LANSING, Mich. — There's more than one way to silence gene activity, according to a Michigan State University researcher. Downregulating activity is how healthy genes should shift out of their development cycle. The results, published in this week's Current Biology, discuss how specific repressor proteins – which researchers have named Hairy and Knirps – slow genes during development and how the process is comparable to slowing down a car, says molecular biologist David Arnosti. The binding of repressor proteins to DNA provides a molecular switch for such regulation. ...

LAST 30 PRESS RELEASES:

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

[Press-News.org] Rare gene glitch may hold clues for schizophrenia -- NIH-funded study
A North Star amid 'a constellation of multiple rare diseases'